Your admitted high roller approach to investing in DNAG is intriguing. Exactly what do you see in this company which offers you at least some assurance that you will at least not take a loss in your investment? Yes, many here are frothing at the mouth over the technology which, so far after 6 years, has been proven unpatentable and incapable of garnering any acceptance from a significant biotech/pharma company. Do you know something different from all this gloom?
Market Data 
Markets 
AI
